BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kartalci S, Karabulut AB, Erbay LG, Acar C. Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia. J ECT 2016;32:174-9. [PMID: 26886746 DOI: 10.1097/YCT.0000000000000303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Rojas M, Ariza D, Ortega Á, Riaño-garzón ME, Chávez-castillo M, Pérez JL, Cudris-torres L, Bautista MJ, Medina-ortiz O, Rojas-quintero J, Bermúdez V. Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications. IJMS 2022;23:6918. [DOI: 10.3390/ijms23136918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abelaira HM, Rosa T, de Moura AB, Andrade NM, Martinello NS, Maciel LR, Botelho MEM, Borba LA, Chede BC, Arent CO, Joaquim L, Bonfante S, Danielski LG, Tuon T, Petronilho F, Quevedo J, Réus GZ. Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats. Mol Neurobiol 2022. [PMID: 34994953 DOI: 10.1007/s12035-021-02718-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lin HT, Liu SK, Hsieh MH, Chien YL, Chen IM, Liao SC, Tsai HJ, Wu CS. Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study. Schizophr Bull 2018;44:798-806. [PMID: 29036711 DOI: 10.1093/schbul/sbx136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
4 Fond G, Godin O, Boyer L, Berna F, Andrianarisoa M, Coulon N, Brunel L, Bulzacka E, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Schürhoff F, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci 2019;269:985-92. [PMID: 29808267 DOI: 10.1007/s00406-018-0908-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
5 Jiang J, Wang J, Li C. Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy. Neurosci Bull 2017;33:339-47. [PMID: 28032314 DOI: 10.1007/s12264-016-0094-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
6 Yu X, Correll CU, Xiang YT, Xu Y, Huang J, Yang F, Wang G, Si T, Kane JM, Masand P. Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review. Shanghai Arch Psychiatry 2016;28:241-52. [PMID: 28638198 DOI: 10.11919/j.issn.1002-0829.216072] [Cited by in F6Publishing: 3] [Reference Citation Analysis]